Jasper Therapeutics, Inc. (JSPR) stock
JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$13.68+0.31 (+2.32%)
Close on Nov 13, 2026Market cap $455.20MP/E –Yield –
Jasper Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Jasper Therapeutics's market cap was $414.45M on Nov 11, 2026, against $1.54B a year earlier. Over the last 5 years it ranged from $24.53M to $11.75B, with a median of $2.20B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $414.45M | -73.0% |
| 2025 | Dec 31, 2025 | $1.54B | -84.0% |
| 2024 | Dec 31, 2024 | $9.62B | +266.9% |
| 2023 | Dec 29, 2023 | $2.62B | +379.5% |
| 2022 | Dec 30, 2022 | $546.97M | -93.9% |
| 2021 | Dec 31, 2021 | $8.91B | +3928.2% |
| 2020 | Dec 31, 2020 | $221.11M | – |
See a number that looks wrong?